PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27448760 ↗2016Reported benefit

Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury.

MouseEndotoxin/LPSC57BL/6n = 6 to 8 mice per groupIntratrachealMitoxantrone 0.25 mg/kg body weight; lentiviral USP11 shRNA…Mitoxantrone given intratracheally prior to lipopolysaccharide challenge; lenti…

Model: Intratracheal lipopolysaccharide induced acute lung injury (2 mg/kg body weight for 24 h)

Both lentiviral knockdown of USP11 and intratracheal mitoxantrone attenuated lipopolysaccharide induced increases in bronchoalveolar lavage protein, IL-6 and KC, and reduced neutrophil influx into alveolar spaces, consistent with reduced LPA1 stability and diminished LPA1-CD14 signalling.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.